Put Options

26 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $18.7 Million - $22.7 Million
-114,000 Reduced 30.57%
258,900 $51.1 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $11.2 Million - $13.1 Million
72,400 Added 24.09%
372,900 $64 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $7.43 Million - $8.37 Million
54,000 Added 21.91%
300,500 $46.6 Million
Q3 2023

Nov 15, 2023

SELL
$133.59 - $154.65 $240,462 - $278,370
-1,800 Reduced 0.72%
246,500 $36.7 Million
Q2 2023

Aug 23, 2023

BUY
$132.51 - $164.9 $1.97 Million - $2.46 Million
14,900 Added 6.38%
248,300 $33.5 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $110 Million - $127 Million
-761,800 Reduced 76.55%
233,400 $36.9 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $111 Million - $134 Million
805,700 Added 425.17%
995,200 $161 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $818,681 - $938,973
-6,100 Reduced 3.12%
189,500 $27 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $10.4 Million - $13.2 Million
-75,600 Reduced 27.88%
195,600 $30.2 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $26 Million - $32.2 Million
-196,800 Reduced 42.05%
271,200 $44.4 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $11.3 Million - $14.3 Million
105,400 Added 29.07%
468,000 $63.6 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $10.8 Million - $12.2 Million
-101,300 Reduced 21.84%
362,600 $39.5 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $11.2 Million - $12.5 Million
106,300 Added 29.73%
463,900 $52.1 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $2.35 Million - $2.59 Million
-23,000 Reduced 6.04%
357,600 $38.2 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $4.98 Million - $6.73 Million
61,900 Added 19.42%
380,600 $40.1 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $4.59 Million - $5.38 Million
53,400 Added 20.13%
318,700 $27.7 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $8.89 Million - $11.9 Million
-121,200 Reduced 31.36%
265,300 $25.6 Million
Q1 2020

May 11, 2020

SELL
$64.5 - $97.79 $4.84 Million - $7.34 Million
-75,100 Reduced 16.27%
386,500 $29.1 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $8.4 Million - $10.5 Million
116,500 Added 33.76%
461,600 $40.9 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $4.58 Million - $5.51 Million
72,800 Added 26.74%
345,100 $25.8 Million
Q2 2019

Aug 20, 2019

SELL
$65.7 - $83.98 $4.66 Million - $5.95 Million
-70,900 Reduced 20.66%
272,300 $19.8 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $1.46 Million - $1.72 Million
18,900 Added 5.83%
343,200 $27.7 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $3.3 Million - $4.07 Million
42,400 Added 15.04%
324,300 $29.6 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $7.3 Million - $8.11 Million
-82,100 Reduced 22.55%
281,900 $26.7 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $4.2 Million - $5.62 Million
-45,600 Reduced 11.13%
364,000 $34.5 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $36.7 Million - $40.2 Million
409,600
409,600 $39.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.